216 related articles for article (PubMed ID: 11857442)
21. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development.
Minchiotti G; Parisi S; Liguori G; Signore M; Lania G; Adamson ED; Lago CT; Persico MG
Mech Dev; 2000 Feb; 90(2):133-42. PubMed ID: 10640699
[TBL] [Abstract][Full Text] [Related]
22. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
23. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
Chu J; Ding J; Jeays-Ward K; Price SM; Placzek M; Shen MM
Development; 2005 Dec; 132(24):5539-51. PubMed ID: 16291788
[TBL] [Abstract][Full Text] [Related]
24. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
Gray PC; Shani G; Aung K; Kelber J; Vale W
Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
[TBL] [Abstract][Full Text] [Related]
25. Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line.
Baldassarre G; Bianco C; Tortora G; Ruggiero A; Moasser M; Dmitrovsky E; Bianco AR; Ciardiello F
Int J Cancer; 1996 May; 66(4):538-43. PubMed ID: 8635871
[TBL] [Abstract][Full Text] [Related]
26. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
[TBL] [Abstract][Full Text] [Related]
27. Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo.
Ding J; Yang L; Yan YT; Chen A; Desai N; Wynshaw-Boris A; Shen MM
Nature; 1998 Oct; 395(6703):702-7. PubMed ID: 9790191
[TBL] [Abstract][Full Text] [Related]
28. Identification and biological characterization of an epidermal growth factor-related protein: cripto-1.
Brandt R; Normanno N; Gullick WJ; Lin JH; Harkins R; Schneider D; Jones BW; Ciardiello F; Persico MG; Armenante F
J Biol Chem; 1994 Jun; 269(25):17320-8. PubMed ID: 8006041
[TBL] [Abstract][Full Text] [Related]
29. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
[TBL] [Abstract][Full Text] [Related]
30. Cripto-1: an embryonic gene that promotes tumorigenesis.
de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
[TBL] [Abstract][Full Text] [Related]
31. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
Strizzi L; Bianco C; Raafat A; Abdallah W; Chang C; Raafat D; Hirota M; Hamada S; Sun Y; Normanno N; Callahan R; Hinck L; Salomon D
J Cell Sci; 2005 Oct; 118(Pt 20):4633-43. PubMed ID: 16176936
[TBL] [Abstract][Full Text] [Related]
32. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
Friess H; Yamanaka Y; Büchler M; Kobrin MS; Tahara E; Korc M
Int J Cancer; 1994 Mar; 56(5):668-74. PubMed ID: 8314343
[TBL] [Abstract][Full Text] [Related]
33. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
[TBL] [Abstract][Full Text] [Related]
34. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia.
Salomon DS; Bianco C; De Santis M
Bioessays; 1999 Jan; 21(1):61-70. PubMed ID: 10070255
[TBL] [Abstract][Full Text] [Related]
35. Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
Klauzinska M; McCurdy D; Rangel MC; Vaidyanath A; Castro NP; Shen MM; Gonzales M; Bertolette D; Bianco C; Callahan R; Salomon DS; Raafat A
Am J Pathol; 2015 Nov; 185(11):2907-22. PubMed ID: 26429739
[TBL] [Abstract][Full Text] [Related]
36. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
Saeki T; Stromberg K; Qi CF; Gullick WJ; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson GR; Salomon DS
Cancer Res; 1992 Jun; 52(12):3467-73. PubMed ID: 1596904
[TBL] [Abstract][Full Text] [Related]
37. The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma.
Yoon HJ; Hong JS; Shin WJ; Lee YJ; Hong KO; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Nov; 47(11):1023-31. PubMed ID: 21824804
[TBL] [Abstract][Full Text] [Related]
38. Identification of Cripto-1 in human milk.
Bianco C; Wechselberger C; Ebert A; Khan NI; Sun Y; Salomon DS
Breast Cancer Res Treat; 2001 Mar; 66(1):1-7. PubMed ID: 11368405
[TBL] [Abstract][Full Text] [Related]
39. Fucosylation of Cripto is required for its ability to facilitate nodal signaling.
Schiffer SG; Foley S; Kaffashan A; Hronowski X; Zichittella AE; Yeo CY; Miatkowski K; Adkins HB; Damon B; Whitman M; Salomon D; Sanicola M; Williams KP
J Biol Chem; 2001 Oct; 276(41):37769-78. PubMed ID: 11500501
[TBL] [Abstract][Full Text] [Related]
40. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]